Log In
BCIQ
Print this Print this
 

OXB-102

  Manage Alerts
Collapse Summary General Information
Company Oxford BioMedica plc
DescriptionLentiviral vector-based therapy
Molecular Target Not applicable
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today